Trial Profile
A retrospective, observational study of Interferon-beta-1a in patients with relapsing-remitting Multiple-sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 14 Sep 2016 New trial record.